Key result
In Mexican Americans with type 2 diabetes, the combination of high triglycerides, elevated TNFα and IL6, and low HDL-C was associated with a 20-fold increased odds of heart attack.
Why the study?
Increasing rates of type 2 diabetes underscore the need for early diagnosis of cardiovascular disease, leading the authors to evaluate dyslipidemia and proinflammatory cytokines as predictive biomarkers for CVD risk in diabetes.
Do elevated triglycerides and pro-inflammatory cytokines increase the risk of cardiovascular disease in Mexican Americans with type 2 diabetes?
Cross-Sectional (n=215)
No
Do elevated triglycerides and pro-inflammatory cytokines increase the risk of cardiovascular disease in Mexican Americans with type 2 diabetes?
The combination of elevated triglycerides, pro-inflammatory cytokines, and low HDL-C significantly amplifies the odds of cardiovascular events in Mexican Americans with type 2 diabetes.
Sedentary life styles coupled with high-calorie diets and unhealthy social habits such as smoking, have put an ever-increasing number of people at risk of cardiovascular disorders (CVD), worldwide. A concomitant increase in the prevalence of type 2-diabetes (hyperglycemia), a risk factor for CVD, has further contributed towards escalating CVD-related mortalities. The increase in number of cases of type 2-diabetes underscores the importance of early diagnosis of cardiovascular disease in those with diabetes. In this work, we have evaluated the sensitivity and specificity of dyslipidemia and proinflammatory cytokines to be used as biomarkers for predicting the risk of CVD in those with diabetes. We hypothesize that interplay between dyslipidemia and diabetes-induced low-grade inflammation in those with type 2-diabetes increases the risk of CVD. A total of 215 participants were randomly recruited from the Cameron County Hispanic Cohort (CCHC). Of these, 99% were Mexican Americans living on Texas-Mexico border. Levels of cytokines, adipokines and lipid profile were measured. Cardiovascular disease (CVD) for this study was defined as prior diagnosis of heart attack, angina and stroke, while diabetes was defined by fasting blood glucose (FBG) of > 100 mg/dL and HbA1c of > 6.5, in accordance with American Diabetes Association (ADA) guidelines. Depending on type and distribution of data, various statistical tests were performed. Our results demonstrated higher rates of heart attack (14% vs 11.8%) and stroke (19.8% vs 10%) in those with diabetes as compared to non-diabetes. The odds of having a heart attack were eight times higher in the presence of elevated triglycerides and pro-inflammatory markers (TNFα and IL6) as compared to presence of pro-inflammatory markers only. The odds for heart attack among those with diabetes, increased by 20 fold in presence of high levels of triglycerides, TNFα, and IL6 when coupled with low levels of high-density lipid cholesterol (HDL-C). Lastly, our analysis showed that poorly controlled diabetes, characterized by HbA1c values of > 6.5 increases the odds of stroke by more than three fold. The study quantifies the role of lipid profile and pro-inflammatory markers in combination with standard risk factors towards predicting the risk of CVD in those with type 2-diabetes. The findings from the study can be directly translated for use in early diagnosis of heart disease and guiding interventions leading to a reduction in CVD-associated mortality in those with type 2-diabetes.
No takes yet. Share an insight, caveat, or question.
Tahir et al. (2021) conducted a cross-sectional in Type 2 diabetes and cardiovascular disease (n=215). Elevated triglycerides, TNFα, IL6, and low HDL-C vs. Without elevated markers was evaluated on Heart attack (OR 20.594, p=0.007). In Mexican Americans with type 2 diabetes, the combination of high triglycerides, elevated TNFα and IL6, and low HDL-C was associated with a 20-fold increased odds of heart attack.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: